Analyst Consensus ?
ConsensusBuy39 ratings
Bullish2256.4%
Neutral1641.0%
Bearish12.6%
FN2 Earnings Intelligence
DuPont de Nemours, Inc. complete analyst coverage
DuPont de Nemours, Inc. (DD) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$126.99Previous close
$32.64Low
$52.8Average
$178High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Overweight | Maintain | Aug 10, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 7, 2026 |
| UBS | Buy | Buy | Maintain | Aug 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 2, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 23, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 21, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Feb 18, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 12, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 11, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Feb 11, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 11, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Dec 18, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | Apr 29, 2025 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 9, 2022 |
| Vertical Research | Buy | Hold | Upgrade | Nov 3, 2021 |
| Argus Research | Buy | Buy | Maintain | May 14, 2021 |
| Goldman Sachs | Buy | Neutral | Upgrade | May 11, 2021 |
| DZ Bank | Hold | Sell | Upgrade | Feb 11, 2021 |
| Exane BNP Paribas | Neutral | Outperform | Downgrade | Jan 28, 2021 |
| Susquehanna | Neutral | Positive | Downgrade | Jan 27, 2021 |
| HSBC | Hold | Buy | Downgrade | Jan 13, 2021 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Aug 3, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 6, 2020 |
| CFRA | Buy | Buy | Maintain | May 5, 2020 |
| Gordon Haskett | Buy | Buy | Maintain | Jan 14, 2020 |
| Bank of America | Buy | Buy | Maintain | Nov 11, 2019 |
| Citi | Buy | Buy | Maintain | Aug 2, 2019 |
| Nomura | Neutral | Neutral | Maintain | Jun 13, 2019 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jun 10, 2019 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Bernstein | Outperform | Outperform | Maintain | Sep 1, 2017 |
| CLSA | Underperform | Outperform | Downgrade | Apr 27, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Jul 29, 2015 |
| BGC Financial | Buy | Hold | Upgrade | Sep 19, 2014 |
| PiperJaffray | Neutral | Neutral | Maintain | Jun 5, 2013 |
| Piper Sandler | Neutral | Neutral | Maintain | Jun 5, 2013 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Oct 24, 2012 |
| Monness Crespi Hardt | Neutral | Buy | Downgrade | Oct 24, 2012 |
| S&P Capital IQ | Buy | Hold | Upgrade | Jul 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $126.99. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $178 | $145.59 | +40.2% | Aug 5, 2026 |
| Goldman Sachs | Joe Ritchie | $53 | $48.26 | -58.3% | Jun 15, 2026 |
| RBC Capital | Analyst unavailable | $60 | $50.54 | -52.8% | May 11, 2026 |
| UBS | Analyst unavailable | $59 | $49.69 | -53.5% | May 6, 2026 |
| RBC Capital | Analyst unavailable | $56 | $46.06 | -55.9% | Apr 24, 2026 |
| Deutsche Bank | Analyst unavailable | $58 | $50.87 | -54.3% | Feb 18, 2026 |
| BMO Capital | Analyst unavailable | $60 | $52.31 | -52.8% | Feb 12, 2026 |
| Morgan Stanley | Analyst unavailable | $52 | $51.47 | -59.1% | Feb 11, 2026 |
| UBS | Analyst unavailable | $56 | $50.32 | -55.9% | Feb 11, 2026 |
| RBC Capital | Arun Viswanathan | $161 | $50.35 | +26.8% | Feb 11, 2026 |
| Mizuho Securities | Analyst unavailable | $52 | $49.43 | -59.1% | Feb 11, 2026 |
| KeyBanc | Aleksey Yefremov | $57 | $50.75 | -55.1% | Feb 11, 2026 |
| Deutsche Bank | David Begleiter | $46 | $43.88 | -63.8% | Jan 23, 2026 |
| RBC Capital | Analyst unavailable | $51 | $43.11 | -59.8% | Jan 21, 2026 |
| KeyBanc | Aleksey Yefremov | $51 | $43.4 | -59.8% | Jan 9, 2026 |
| UBS | Joshua Spector | $49 | $42.89 | -61.4% | Jan 7, 2026 |
| Mizuho Securities | Analyst unavailable | $46 | $40.61 | -63.8% | Dec 18, 2025 |
| RBC Capital | Arun Viswanathan | $48 | $38.7 | -62.2% | Nov 18, 2025 |
| Morgan Stanley | Analyst unavailable | $44 | $40.14 | -65.4% | Nov 10, 2025 |
| KeyBanc | Aleksey Yefremov | $45 | $39.69 | -64.6% | Nov 7, 2025 |
| UBS | Joshua Spector | $44 | $39.13 | -65.4% | Nov 5, 2025 |
| BMO Capital | John McNulty | $50 | $34.38 | -60.6% | Nov 3, 2025 |
| Mizuho Securities | Analyst unavailable | $37.66 | $31.71 | -70.3% | Sep 2, 2025 |
| BMO Capital | John McNulty | $44.77 | $32.18 | -64.7% | Aug 29, 2025 |
| New Street | Analyst unavailable | $44.77 | $32.18 | -64.7% | Aug 29, 2025 |
| UBS | Joshua Spector | $36.4 | $31.29 | -71.3% | Jul 9, 2025 |
| UBS | Joshua Spector | $35.56 | $28.41 | -72.0% | May 21, 2025 |
| RBC Capital | Arun Viswanathan | $37.66 | $27.64 | -70.3% | Apr 24, 2025 |
| RBC Capital | Arun Viswanathan | $42.68 | $32.57 | -66.4% | Aug 5, 2024 |
| BMO Capital | John McNulty | $41.84 | $34.64 | -67.1% | Aug 1, 2024 |
| Wells Fargo | Michael Sison | $43.93 | $35.02 | -65.4% | Aug 1, 2024 |
| Barclays | Duffy Fischer | $35.56 | $33.94 | -72.0% | May 28, 2024 |
| Wells Fargo | Michael Sison | $43.1 | $33.03 | -66.1% | May 24, 2024 |
| BMO Capital | John McNulty | $40.17 | $33.09 | -68.4% | May 23, 2024 |
| Mizuho Securities | John Roberts | $41.84 | $33.17 | -67.1% | May 23, 2024 |
| Jefferies | Laurence Alexander | $42.26 | $32.46 | -66.7% | May 17, 2024 |
| RBC Capital | Arun Viswanathan | $36.4 | $32.53 | -71.3% | May 3, 2024 |
| Bank of America Securities | Steve Byrne | $33.47 | $30.85 | -73.6% | Jan 16, 2024 |
| Citigroup | Analyst unavailable | $37.24 | $32.27 | -70.7% | Feb 8, 2023 |
| Wells Fargo | Analyst unavailable | $35.56 | $32.25 | -72.0% | Feb 8, 2023 |
| Barclays | Analyst unavailable | $33.47 | $32.55 | -73.6% | Feb 8, 2023 |
| Citigroup | Analyst unavailable | $34.31 | $29.14 | -73.0% | Dec 15, 2022 |
| Credit Suisse | Analyst unavailable | $35.98 | $27.56 | -71.7% | May 4, 2022 |
| Mizuho Securities | Analyst unavailable | $40.59 | $27.52 | -68.0% | May 4, 2022 |
| Fermium Research | Frank Mitsch | $32.64 | $28.7 | -74.3% | Apr 18, 2022 |
| Deutsche Bank | David Begleiter | $37.66 | $32.11 | -70.3% | Mar 21, 2022 |
| Morgan Stanley | Vincent Andrews | $38.91 | $34.59 | -69.4% | Jan 11, 2022 |
| UBS | John Roberts CFA | $42.68 | $31.33 | -66.4% | Dec 20, 2021 |
| Vertical Research | Jeffrey Sprague | $39.75 | $32.15 | -68.7% | Nov 2, 2021 |
| J.P. Morgan | Stephen Tusa | $35.56 | $29.12 | -72.0% | Oct 4, 2021 |
| Argus Research | Bill Selesky | $38.91 | $34.28 | -69.4% | May 14, 2021 |
| Goldman Sachs | Robert Koort | $42.68 | $34.11 | -66.4% | May 11, 2021 |
Track every rating change on DD the moment it posts. Free to start.
Start free